Exhibit 99.1 Accelerate Diagnostics Reports Third Quarter 2024 Financial Results TUCSON, Ariz., November 7, 2024 -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September 30, 2024. "We are excited by the momentum we're building across our innovation pipeline, underscored by the successful launch of the clinical trial for our WAVE system and the Gram-Negative assay. This quarter also marked a significant milestone with FDA clearance of our Accelera ...